Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		28,127,657
Beginning balance at Dec. 31, 2021	$ 64,412	$ 28	$ 347,374	$ (119)	$ (282,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, warrants and prefunded warrants for the purchase of common stock, net of issuance costs (in shares)		92,461,988
Issuance of common stock, warrants and prefunded warrants for the purchase of common stock, net of issuance costs	59,362	$ 92	59,270
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations (in shares)		372,831
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations	(13)	$ 0	(13)
Exercise of warrants and prefunded warrants (in shares)		499,871
Exercise of warrants and prefunded warrants	1	$ 1
Stock-based compensation expense	$ 5,199		5,199
Issuance of shares under employee stock purchase plan (in shares)	204,903
Issuance of shares under employee stock purchase plan	$ 203	$ 1	202
Reclassification of warrant liability to equity (Note 13)	38,754		38,754
Net loss	(93,867)				(93,867)
Ending balance (in shares) at Dec. 31, 2022		121,667,250
Ending balance at Dec. 31, 2022	74,051	$ 122	450,786	(119)	(376,738)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, warrants and prefunded warrants for the purchase of common stock, net of issuance costs (in shares)		34,521,046
Issuance of common stock, warrants and prefunded warrants for the purchase of common stock, net of issuance costs	60,443	$ 35	60,408
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations (in shares)		3,510,491
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations	0	$ 2	(2)
Exercise of warrants and prefunded warrants (in shares)		7,477,845
Exercise of warrants and prefunded warrants	8,813	$ 8	8,805
Stock-based compensation expense	$ 8,687		8,687
Issuance of shares under employee stock purchase plan (in shares)	257,963
Issuance of shares under employee stock purchase plan	$ 272		272
Net loss	(101,167)				(101,167)
Ending balance (in shares) at Dec. 31, 2023		167,434,595
Ending balance at Dec. 31, 2023	51,099	$ 167	528,956	(119)	(477,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations (in shares)		2,876,806
Vesting of restricted stock units, less shares withheld and retired to satisfy tax obligations	2	$ 3	(1)
Stock-based compensation expense	8,204		8,204
Issuance of shares under employee stock purchase plan (in shares)		635,542
Issuance of shares under employee stock purchase plan	297	$ 1	296
Unrealized losses on marketable securities	(3)			(3)
Net loss	(37,450)				(37,450)
Ending balance (in shares) at Dec. 31, 2024		170,946,943
Ending balance at Dec. 31, 2024	$ 22,149	$ 171	$ 537,455	$ (122)	$ (515,355)